Novocure Ltd - ROE
NVCR
Price:
$15.2
Market Cap:
$1.76B
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally. Its TTFields devices include Optune Gio, Optune Lua, and Optune Pax. The company also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland.
Industry
Medical - Devices
IPO Date
2015-10-02
Stock Exchange
NASDAQ
Ticker
NVCR
PE Ratio
[-9.93]
ROE
[-44.00%]
Current Ratio
[2.89]
Dividend Yield
[0%]
Enterprise Value
[1.90B]
Dividend History
The ROE as of July 2026 (TTM) for Novocure Ltd (NVCR) is -44.00%
According to Novocure Ltd’s latest financial reports and current stock price. The company's current ROE is -44.00%. This represents a change of 297.68% compared to the average of -11.06% of the last 4 quarters.
Novocure Ltd (NVCR) Historical ROE (quarterly & annually)
How has NVCR ROE performed in the past?
The mean historical ROE of Novocure Ltd over the last ten years is -38.18%. The current -44.00% ROE has changed 15.23% with respect to the historical average. Over the past ten years (40 quarters), NVCR's ROE was at its highest in in the September 2020 quarter at 3.02%. The ROE was at its lowest in in the March 2026 quarter at -21.51%.
Average
-38.18%
Median
-43.41%
Minimum
-92.62%
Maximum
4.16%
Novocure Ltd (NVCR) ROE by Quarter and Year
Discovering the peaks and valleys of Novocure Ltd ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 172.31%
Maximum Annual ROE = 4.16%
Minimum Annual Increase = -441.97%
Minimum Annual ROE = -92.62%
| Year | ROE | Change |
|---|---|---|
| 2025 | -40.01% | -14.54% |
| 2024 | -46.82% | -18.03% |
| 2023 | -57.12% | 172.31% |
| 2022 | -20.97% | 47.55% |
| 2021 | -14.21% | -441.97% |
| 2020 | 4.16% | -225.21% |
| 2019 | -3.32% | -94.14% |
| 2018 | -56.62% | 4.27% |
| 2017 | -54.30% | -41.38% |
| 2016 | -92.62% | 108.21% |
Novocure Ltd (NVCR) Average ROE
How has NVCR ROE performed in the past?
The current ROE of Novocure Ltd (NVCR) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-47.98%
5-year avg
-35.83%
10-year avg
-38.18%
Novocure Ltd (NVCR) ROE vs. Peers
How is NVCR’s ROE compared to its peers?
Novocure Ltd’s ROE is greater than Azenta, Inc. (-10.69%), greater than Kestra Medical Technologies, Ltd. (-58.76%), greater than STAAR Surgical Company (-6.07%), greater than BioLife Solutions, Inc. (-2.91%), greater than Neogen Corporation (-29.00%), greater than Evotec SE (-24.55%), greater than Teladoc Health, Inc. (-13.08%), greater than Establishment Labs Holdings Inc. (-225.86%), greater than Pulse Biosciences, Inc. (-86.67%), greater than Upstream Bio, Inc. (-43.82%),
| Company | ROE | Market cap |
|---|---|---|
| -10.69% | $1.30B | |
| -58.76% | $1.33B | |
| -6.07% | $1.19B | |
| -2.91% | $1.54B | |
| -29.00% | $2.05B | |
| -24.55% | $685.51M | |
| -13.08% | $1.66B | |
| -225.86% | $2.71B | |
| -86.67% | $2.37B | |
| -43.82% | $348.83M |
Build a custom stock screener for Novocure Ltd (NVCR) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Novocure Ltd using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Novocure Ltd (NVCR) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Novocure Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Novocure Ltd's ROE?
How is the ROE calculated for Novocure Ltd (NVCR)?
What is the highest ROE for Novocure Ltd (NVCR)?
What is the 3-year average ROE for Novocure Ltd (NVCR)?
What is the 5-year average ROE for Novocure Ltd (NVCR)?
How does the current ROE for Novocure Ltd (NVCR) compare to its historical average?